SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-072559
Filing Date
2021-03-08
Accepted
2021-03-08 11:04:32
Documents
14
Period of Report
2021-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d75995d8k.htm   iXBRL 8-K 28056
2 EX-99.1 d75995dex991.htm EX-99.1 9088
6 GRAPHIC g75995g0308201748749.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-072559.txt   165668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210302.xsd EX-101.SCH 3080
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210302_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210302_pre.xml EX-101.PRE 10959
7 EXTRACTED XBRL INSTANCE DOCUMENT d75995d8k_htm.xml XML 3231
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 21720993
SIC: 2834 Pharmaceutical Preparations